Hemostemix Inc.

TSXV Exchange | Aug 24, 2019, 10:31 AM EDT | Real-time price

HEM $ 0.02 RT
0 (0%)
Day Low: N/A
Day High: N/A
Detailed Quote
Open: N/A
High: N/A
Beta: 0.3662
Shares Out.: 283,914,302
Total Shares (All Classes): 300,898,610
Prev. Close: 0.02
Low: N/A
Market Cap: 6,017,972
Market Cap (All Classes)*: 6,017,972
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Total Shares: 300,898,610
EPS: -0.04
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 37.01
Escrow Shares: 16,984,308
Exchange: TSXV
*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Hemostemix Inc is a Canada based clinical-stage biotechnology company. Its principal business activity is to develop, manufacture and commercialize blood-derived cell therapies for medical conditions. The company's technology platform for developing autologous cell therapies is for treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia. More

News Headlines for Hemostemix Inc.
Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links
News Headlines for Hemostemix Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.